Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 3Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 138NIH 38INDUSTRY 28OTHER_GOV 5UNKNOWN 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Breast Neoplasms 33Esophageal Neoplasms 14Stomach Neoplasms 11Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Colorectal Neoplasms 8Small Cell Lung Carcinoma 7Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Brain Neoplasms 6Neoplasms 5Esophageal Squamous Cell Carcinoma 5Recurrence 3Nasopharyngeal Carcinoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3Head and Neck Neoplasms 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Radiation Injuries 2Papillomavirus Infections 2Carcinoma, Small Cell 2Carcinoma, Hepatocellular 2

Interventions

Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Lymphoma, Large B-Cell, Diffuse × Clear all
NCT04425824 2020-06-16

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

ChineseAMS

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04023916 2019-12-11

Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

ChineseAMS

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT01156259 2010-07-02

30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy

ChineseAMS

Phase 3 Unknown
400 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡